Corneal biomechanical changes of SMILE versus LASIK

Article

Patients with myopia of greater than -6.00 dioptres (D) who underwent femtosecond laser-assisted LASIK, experienced a more significant decrease in corneal hysteresis, corneal resistance factor, and p1 and p2 areas than patients who underwent small incision lenticule extraction (SMILE).

Patients with myopia of greater than -6.00 dioptres (D) who underwent femtosecond laser-assisted LASIK, experienced a more significant decrease in corneal hysteresis, corneal resistance factor, and p1 and p2 areas than patients who underwent small incision lenticule extraction (SMILE).

Researchers in China studied 187 eyes that were treated with SMILE and 79 eyes that were treated with LASIK. The eyes were also grouped by degree of myopia: -68.00 D or less, or greater than -6.00 D. In all patients, corneal hysteresis, corneal resistance factor, and 37 waveform parameters were compared preoperatively, and at 1 week and 1 and 3 months postoperatively.

Using an Ocular Response Analyzer (Reichert Ophthalmic Instruments) the researchers noted in both the SMILE patients and the LASIK patients a significant decrease of corneal hysteresis, corneal resistance factor, p1 area, and p2 area. The differences in these parameters between the two procedures were not significant in patients who had myopia of -6.00 D or less. However, in patients with myopia greater than -6.00 D, all of the parameters decreased significantly more in the eyes that underwent LASIK than in those that underwent SMILE.

The findings were reported in the Journal of Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.